Exelixis has mixed ruling in Cabometyx patent trial, wins in 2026, loses in 2030
sanjeri/E+ via Getty Images Update 20:15: Add Exelixis's comment. exélixis (NASDAQ:EXEL) had a mixed ruling in its Cabometyx vs. MSN ...
sanjeri/E+ via Getty Images Update 20:15: Add Exelixis's comment. exélixis (NASDAQ:EXEL) had a mixed ruling in its Cabometyx vs. MSN ...